Brian P. Mulherin, MD

home / authors / brian-p-mulherin-md

Articles

A panel of 4 experts on PNH
July 24th 2024

Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

Ryan Haumschild, PharmD, MS, MBA Jamie L. Koprivnikar, MD David Dingli, MD, PhD Brian P. Mulherin, MD

The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.

A panel of 4 experts on PNH
July 24th 2024

Ensuring PNH Treatment Access and Adherence to Therapies

Ryan Haumschild, PharmD, MS, MBA Jamie L. Koprivnikar, MD David Dingli, MD, PhD Brian P. Mulherin, MD

Barriers to care and treatment adherence for patients diagnosed with PNH is discussed.

Latest Updated Articles

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Children with SMA are commonly affected by low bone mineral density | image credit: PT - stock.adobe.com
Published: November 13th 2024 | Updated: November 15th 2024
Low Bone Mineral Density Risk Increases with Age in SMA
Glaucoma | Image credit: Yakobchuk Olena - stock.adobe.com
Published: November 12th 2024 | Updated: November 15th 2024
Polygenic Risk Score Important to Track POAG Onset

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo